AI for life sciences

Certara provides drug development solutions including predictive simulation, data-driven modeling, and AI tailored for drug development. The company offers software, services, and consulting across discovery, preclinical, clinical, regulatory, and market access phases, serving biotech, pharma, and CROs. Certara has over 1,550 employees in more than 30 countries, over 28% of whom have PhDs.

Read more

biometrics and data sciencebiosimulationdata standardization and validationeCTD submissionsmodel-informed drug developmentmodeling and simulationPBPK modelingreal-world evidenceregulatory strategy